Daniel J. Curran - 20 Jan 2026 Form 4 Insider Report for ALX ONCOLOGY HOLDINGS INC (ALXO)

Role
Director
Signature
/s/ Shelly Pinto, by power of attorney
Issuer symbol
ALXO
Transactions as of
20 Jan 2026
Net transactions value
$0
Form type
4
Filing time
21 Jan 2026, 16:30:06 UTC
Previous filing
24 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Curran Daniel J. Director C/O ALX ONCOLOGY HOLDINGS INC., 323 ALLERTON AVENUE, SOUTH SAN FRANCISCO /s/ Shelly Pinto, by power of attorney 21 Jan 2026 0001887599

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALXO Stock Option (right to buy) Award $0 +16,833 $0.000000 16,833 20 Jan 2026 Common Stock 16,833 $1.32 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares subject to the option vest in 12 equal monthly installments beginning on February 20, 2026.